Equities research analysts at Lazard Capital Markets increased their price target on shares of AmerisourceBergen (NYSE: ABC)
A number of other analysts have also recently weighed in on ABC. Analysts at ISI Group downgraded shares of AmerisourceBergen from a ?strong-buy? rating to a ?buy? rating in a research note to investors on Tuesday. They now have a $53.00 price target on the stock, up previously from $51.50. They noted that the move was a valuation call. Separately, analysts at Raymond James reiterated a ?strong-buy? rating on shares of AmerisourceBergen in a research note to investors on Tuesday, February 12th. They now have a $52.00 price target on the stock. Finally, analysts at UBS AG raised their price target on shares of AmerisourceBergen from $45.00 to $51.00 in a research note to investors on Wednesday, January 23rd. They now have a ?buy? rating on the stock.
Seven analysts have rated the stock with a buy rating, three have given an overweight rating, and seven have given a hold rating to the company?s stock. The stock presently has a consensus rating of ?overweight? and an average target price of $49.64.
AmerisourceBergen traded up 0.83% on Friday, hitting $48.48. AmerisourceBergen has a 1-year low of $35.48 and a 1-year high of $48.80. The stock?s 50-day moving average is currently $46.65. The company has a market cap of $11.159 billion and a price-to-earnings ratio of 16.56.
AmerisourceBergen last posted its quarterly earnings results on Thursday, January 24th. The company reported $0.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.67 by $0.02. The company had revenue of $21.50 billion for the quarter, compared to the consensus estimate of $21.69 billion. During the same quarter in the previous year, the company posted $0.62 earnings per share. The company?s revenue for the quarter was up 5.7% on a year-over-year basis. AmerisourceBergen has set its FY13 guidance at $3.06-3.16 EPS. Analysts expect that AmerisourceBergen will post $3.15 EPS for the current fiscal year.
AmerisourceBergen Corporation (AmerisourceBergen) is a pharmaceutical services company, with operations primarily in the United States and Canada.